Downregulation of SNCA Expression as a Therapoetic Approach for Parkinson's Disease and Other Synucleinopathies: New Target Validation for Next-Generation Drug Discovery
Publication
, Conference
Kantor, B; Dong, W; Rittiner, J; Poe, J; Chiba-Falek, O
Published in: MOLECULAR THERAPY
2021
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2021
Volume
29
Issue
4
Start / End Page
265 / 266
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kantor, B., Dong, W., Rittiner, J., Poe, J., & Chiba-Falek, O. (2021). Downregulation of SNCA Expression as a Therapoetic Approach for Parkinson's Disease and Other Synucleinopathies: New Target Validation for Next-Generation Drug Discovery. In MOLECULAR THERAPY (Vol. 29, pp. 265–266).
Kantor, Boris, Wendy Dong, Joseph Rittiner, Jordan Poe, and Ornit Chiba-Falek. “Downregulation of SNCA Expression as a Therapoetic Approach for Parkinson's Disease and Other Synucleinopathies: New Target Validation for Next-Generation Drug Discovery.” In MOLECULAR THERAPY, 29:265–66, 2021.
Kantor B, Dong W, Rittiner J, Poe J, Chiba-Falek O. Downregulation of SNCA Expression as a Therapoetic Approach for Parkinson's Disease and Other Synucleinopathies: New Target Validation for Next-Generation Drug Discovery. In: MOLECULAR THERAPY. 2021. p. 265–6.
Kantor, Boris, et al. “Downregulation of SNCA Expression as a Therapoetic Approach for Parkinson's Disease and Other Synucleinopathies: New Target Validation for Next-Generation Drug Discovery.” MOLECULAR THERAPY, vol. 29, no. 4, 2021, pp. 265–66.
Kantor B, Dong W, Rittiner J, Poe J, Chiba-Falek O. Downregulation of SNCA Expression as a Therapoetic Approach for Parkinson's Disease and Other Synucleinopathies: New Target Validation for Next-Generation Drug Discovery. MOLECULAR THERAPY. 2021. p. 265–266.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2021
Volume
29
Issue
4
Start / End Page
265 / 266
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences